These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. New migraine and pain research. Hargreaves R Headache; 2007 Apr; 47 Suppl 1():S26-43. PubMed ID: 17425708 [TBL] [Abstract][Full Text] [Related]
5. An introduction to migraine: from ancient treatment to functional pharmacology and antimigraine therapy. Villalón CM; Centurión D; Valdivia LF; De Vries P; Saxena PR Proc West Pharmacol Soc; 2002; 45():199-210. PubMed ID: 12434581 [TBL] [Abstract][Full Text] [Related]
6. Can we develop neurally acting drugs for the treatment of migraine? Goadsby PJ Nat Rev Drug Discov; 2005 Sep; 4(9):741-50. PubMed ID: 16121129 [TBL] [Abstract][Full Text] [Related]
7. [Pharmacologic treatment of acute migraine attack in children]. Cuvellier JC; Joriot S; Auvin S; Vallée L Arch Pediatr; 2005 Mar; 12(3):316-25. PubMed ID: 15734131 [TBL] [Abstract][Full Text] [Related]
8. Major therapeutic advances in the past 25 years. Solomon S Headache; 2007 Apr; 47 Suppl 1():S20-2. PubMed ID: 17425706 [No Abstract] [Full Text] [Related]
9. Development of human calcitonin gene-related peptide (CGRP) receptor antagonists. 1. Potent and selective small molecule CGRP antagonists. 1-[N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-l-lysyl]-4-(4-pyridinyl)piperazine: the first CGRP antagonist for clinical trials in acute migraine. Rudolf K; Eberlein W; Engel W; Pieper H; Entzeroth M; Hallermayer G; Doods H J Med Chem; 2005 Sep; 48(19):5921-31. PubMed ID: 16161996 [TBL] [Abstract][Full Text] [Related]
10. Emerging migraine treatments and drug targets. Olesen J; Ashina M Trends Pharmacol Sci; 2011 Jun; 32(6):352-9. PubMed ID: 21459461 [TBL] [Abstract][Full Text] [Related]
12. [New prospects in the treatment of migraine]. Pascual J Neurologia; 1999 Dec; 14 Suppl 6():26-35. PubMed ID: 10659603 [TBL] [Abstract][Full Text] [Related]
13. Serotonin receptors and the acute attack of migraine. Goadsby PJ Clin Neurosci; 1998; 5(1):18-23. PubMed ID: 9523053 [TBL] [Abstract][Full Text] [Related]
14. [Treatment and prophylaxis of an acute migraine attack]. Diener HC; Gendolla A MMW Fortschr Med; 2004 Sep; 146(35-36):41, 43-5. PubMed ID: 15540539 [TBL] [Abstract][Full Text] [Related]
15. [Physiopathology of the migraine attack and mechanisms of action of anti-migraine agents: recent findings in animals]. Mick G Pathol Biol (Paris); 2000 Sep; 48(7):593-607. PubMed ID: 11072637 [TBL] [Abstract][Full Text] [Related]
16. Sumatriptan and naproxen sodium for the acute treatment of migraine. Smith TR; Sunshine A; Stark SR; Littlefield DE; Spruill SE; Alexander WJ Headache; 2005 Sep; 45(8):983-91. PubMed ID: 16109111 [TBL] [Abstract][Full Text] [Related]
17. Migraine: new treatment options from molecular biology. Stam AH; Haan J; Frants RR; Ferrari MD; van den Maagdenberg AM Expert Rev Neurother; 2005 Sep; 5(5):653-61. PubMed ID: 16162089 [TBL] [Abstract][Full Text] [Related]